| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000007308 |
| Receipt No. | R000008616 |
| Official scientific title of the study | RenalGuard System to Prevent Contrast-Induced Acute Kidney Injury in Japan |
| Date of disclosure of the study information | 2012/02/16 |
| Last modified on | 2018/09/13 (Ver. 7) |
| Basic information | ||
| Official scientific title of the study | RenalGuard System to Prevent Contrast-Induced Acute Kidney Injury in Japan | |
| Title of the study (Brief title) | RESPECT KIDNEY | |
| Region |
|
|
| Condition | ||||
| Condition | Chronic kidney disease with coronary aretry disease or peripheral artery disease | |||
| Classification by specialty |
|
|||
| Classification by malignancy | Others | |||
| Genomic information | NO | |||
| Objectives | |
| Narrative objectives1 | To evaluate safety and efficacy of RenalGuard System in the prevention of contrast-induced nephropathy in the setting of a catheterization laboratory |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Combined incidence of contrast-induced nephropathy (CIN) and serious in-hospital therapy-related adverse events |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | RenalGuard group | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Male or non-pregnant female equal or greater than the age 20 years old and is able to provide informed consent.
Subject is scheduled to undergo an catheterization procedure that is expected to use at least 75 ml of intraarterial contrast. Subject has moderate to severe kidney impairement-eGFR<45 ml/min/1.73m2 and more than 30 % of ejection fraction of left ventricle. |
|||
| Key exclusion criteria | Class 3 or 4 chronic heart failure.
Subject is anuric or has undergone renal replacement therapy, or has a known inability to have a Foley catheter placed. Subject has received contrast within 7 days of procedure. Subject has a known hypersensitivity to furosemide and/or the contrast agent being used. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Ichiro Michishita |
| Organization | Federation of National Public Service Personnel Mutual Aid Associations, Yokohama Sakae Kyosai Hospital |
| Division name | Division of Cardiology, Department of Internal Medicine |
| Address | 132 Katura-cho, Sakae-ku, Yokohama-shi |
| TEL | 045-891-2171 |
| i-michishita@yokohamasakae.jp | |
| Public contact | |
| Name of contact person | Tsuyoshi Nozue |
| Organization | Yokohama Sakae Kyosai Hospital |
| Division name | Divison of Cardiology, Department of Internal Medicine |
| Address | 132 Katsura-cho, Sakae-ku, Yokohama-shi |
| TEL | 045-891-2171 |
| Homepage URL | |
| nozue2493@yahoo.co.jp | |
| Sponsor | |
| Institute | Yokohama Sakae Kyosai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Yokohama Sakae Kyosai Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000008616 |